Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth

被引：0
|
作者：
Yuzhu Wang
Tao He
James G. Herman
Enqiang Linghu
Yunsheng Yang
François Fuks
Fuyou Zhou
Linjie Song
Mingzhou Guo
机构：
[1] Chinese PLA General Hospital,Department of Gastroenterology & Hepatology
[2] Chinese PLA Navy General Hospital,Department of Geriatric Digestive System
[3] University of Pittsburgh Cancer Institute,The Hillman Cancer Center
[4] Free University of Brussels (U.L.B.),Laboratory of Cancer Epigenetics
[5] Anyang Tumor Hospital,Department of Thoracic Surgery
[6] Chinese PLA General Hospital,Department of General Surgery
[7] Medical College of NanKai University,undefined
来源：
Clinical Epigenetics | 2018年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
    Wang, Yuzhu
    He, Tao
    Herman, James G.
    Linghu, Enqiang
    Yang, Yunsheng
    Fuks, Francois
    Zhou, Fuyou
    Song, Linjie
    Guo, Mingzhou
    CLINICAL EPIGENETICS, 2017, 9
  • [2] Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
    Yuzhu Wang
    Tao He
    James G. Herman
    Enqiang Linghu
    Yunsheng Yang
    François Fuks
    Fuyou Zhou
    Linjie Song
    Mingzhou Guo
    Clinical Epigenetics, 2017, 9
  • [3] Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth (vol 9, 115, 2017)
    Wang, Yuzhu
    He, Tao
    Herman, James G.
    Linghu, Enqiang
    Yang, Yunsheng
    Fuks, Francois
    Zhou, Fuyou
    Song, Linjie
    Guo, Mingzhou
    CLINICAL EPIGENETICS, 2018, 10
  • [4] Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
    Hege Marie Vedeld
    Arild Nesbakken
    Ragnhild A. Lothe
    Guro E. Lind
    Clinical Epigenetics, 2018, 10
  • [5] Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
    Vedeld, Hege Marie
    Nesbakken, Arild
    Lothe, Ragnhild A.
    Lind, Guro E.
    CLINICAL EPIGENETICS, 2018, 10
  • [6] Methylation of ZNF331 Promotes Cell Invasion and Migration in Human Esophageal Cancer
    Jiang, Suzhen
    Linghu, Enqiang
    Zhan, Qimin
    Han, Weidong
    Guo, Mingzhou
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2015, 16 (04) : 322 - 328
  • [7] Methylation of serum DNA is an independent prognostic marker in colorectal cancer
    Wallner, Maike
    Herbst, Andreas
    Behrens, Andrea
    Crispin, Alexander
    Stieber, Petra
    Goeke, Burkhard
    Lamerz, Rolf
    Kolligs, Frank T.
    CLINICAL CANCER RESEARCH, 2006, 12 (24) : 7347 - 7352
  • [8] Methylation of serum SST gene is an independent prognostic marker in colorectal cancer
    Liu, Yanqun
    Chew, Min Hoe
    Tham, Chee Kian
    Tang, Choong Leong
    Ong, Simon Y. K.
    Zhao, Yi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (09): : 2098 - 2108
  • [9] Evaluating the utility of ZNF331 promoter methylation as a prognostic and predictive marker in stage III colon cancer: results from CALGB 89803 (Alliance)
    Nakasone, Elizabeth S.
    Zemla, Tyler J.
    Yu, Ming
    Lin, She Yu
    Ou, Fang-Shu
    Carter, Kelly
    Innocenti, Federico
    Saltz, Leonard
    Grady, William M.
    Cohen, Stacey A.
    EPIGENETICS, 2024, 19 (01)
  • [10] Cancer IgG, a potential prognostic marker, promotes colorectal cancer progression
    Jiang, Hongpeng
    Kang, Boxi
    Huang, Xinmei
    Yan, Yichao
    Wang, Shan
    Ye, Yingjiang
    Shen, Zhanlong
    CHINESE JOURNAL OF CANCER RESEARCH, 2019, 31 (03) : 499 - 510
12345